3 years ago

Eosinophilia secondary to lenalidomide therapy

Eosinophilia secondary to lenalidomide therapy
S. Osorio-Prendes, V. Escudero-Vilaplana, E. González-Arias, M. Sanjurjo-Sáez, R. Collado-Borrell
What is known and objective Limited data are available on eosinophilia as a drug adverse event. We describe a case of eosinophilia from lenalidomide therapy. Case description A 50-year-old woman received lenalidomide, dexamethasone and cyclophosphamide as POEMS syndrome treatment. Eosinophil count rose during lenalidomide treatment and decreased in the periods off treatment. Naranjo nomogram suggested a probable association between the use of lenalidomide and eosinophilia. What is new and conclusion Eosinophilia has rarely been described with lenalidomide. This case shows a clear temporal relationship between lenalidomide and eosinophilia. We describe a patient, treated with lenalidomide for POEMS syndrome, who developed eosinophilia secondary to lenalidomide. This observation could increase the knowledge about lenalidomide safety, because, although our patient developed an isolated eosinophilia, it could be associated with life-threatening DRESS. Thus, lenalidomide should be considered as a potential cause of isolated eosinophilia, and if symptoms of DRESS appear, its discontinuation should be strongly considered. This adverse event is extremely uncommon and it is not described in lenalidomide summary of product characteristics.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/jcpt.12611

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.